Effect of rosuvastatin on cardiovascular events and mortality after pneumonia
- Conditions
- Community aquired pneumonia
- Registration Number
- EUCTR2007-004894-25-SE
- Lead Sponsor
- Karolinska University Hospital Huddinge
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
- age 55-85 years old
- CAP diagnose
- Written informed consent
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years)
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years)
F.1.3.1 Number of subjects for this age range
- Previous participation in the study
- pervious participation in any other clinical trial, within 6 months period
- ongoing drug treatment with a statin or any other lipidlowering therapy
- co-morbid condition with a life expectancy less than one year
- serum ASAT or Serum ALAT>times UNL
- serum creatinin kinase (s-CK) > 5 times UNL
- serum kreatinin (S-Krea) > 200µkat/L
-poorly controlledhypothyroid function
- inhereditied myopathia
- alcoholdependecy
- drug treatment with erytromycin, proteas inhibitors, gemfibrozil, ciklosporin, niacin, fibrates (except fenofibrate) and ezetemib
- any other condition after judgement of the investigator would make the patient unsuiteable for enrollment, or could interfere with the study protocol
-preganacy or planned pregnancy or breastfeeding
-
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method